Clinical virology laboratories have adopted measures to guard against transmission of human immunodeficiency virus (HIV) type 1, emphasizing the need for extremely careful processing of clinical specimens. However, biosafety procedures are sometimes abandoned after the initial processing of the specimens, perhaps because of knowledge that HIV does not replicate in cell culture systems commonly used by clinical virology laboratories (6) . The recovery of HIV after inoculation of a blood specimen from a patient into standard viral culture systems would reinforce the need for compliance with comprehensive laboratory safety practices in clinical virology laboratories. Therefore, we studied the survival of HIV in cell cultures used to isolate the common pathogens associated with acute human viral disease.
(This material was presented in part at the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, Calif., 23 to 26 October 1988.) Twenty-six whole-blood samples were obtained from 24 HIV antibody-positive patients at various stages of HIV infection: asymptomatic (13 patients, 14 samples); acquired immunodeficiency syndrome (AIDS)-related complex (6 patients, 7 samples); and AIDS (5 patients, 5 samples). Each specimen was divided into a 10-ml portion for routine viral isolation and a 30-ml portion for HIV culture and serum antigen detection.
Routine viral cultures. Peripheral blood mononuclear cells (PBMC) were separated from 10 ml of heparinized blood on lymphocyte separation medium (Organon Teknika Corp., Durham, N.C.) and suspended in 1 ml of maintenance medium (GIBCO Laboratories, Grand Island, N.Y.) with 2% fetal bovine serum, 1% L-glutamine, penicillin G (200 p.g/ml), amphotericin B (250 F.g/ml), and gentamicin (50 mg/ml). A 0.1-ml portion was inoculated into single tubes of each of three types of cell culture routinely used for viral isolation in the Clinical Virology Laboratory of the University of Minnesota Health Sciences Center. These cell cultures were human skin fibroblasts (SF), primary rhesus monkey kidney cells (RHMK), and a human lung carcinoma line (A549) acquired from the American Type Culture Collection (Rockville, Md.). The cultures were incubated at 37°C in a 5% CO, atmosphere for up to 28 days. Media from the A549 and RHMK cultures were changed and frozen on days 1, 4, and 7, and media from the SF cultures were changed and frozen * Corresponding author. on days 1, 4, 11, 18, and 25. These cultures were also examined microscopically daily for characteristic cytopathic effects.
HIV culture and antigen detection. PBMC were cultured for HIV as described elsewhere (5). Supernatant fluids from HIV cultures and routine viral cultures were tested for the presence of HIV antigen by using an enzyme-linked immunosorbent assay (Abbott Laboratories, North Chicago, Ill.). This assay primarily detects the core antigen (p24) of HIV and has a lower limit of detection of 30 to 50 pg/ml (1). This same assay was used to detect HIV antigen in patient sera.
Coculture of routine viral-culture supernatants. Approximately 1 ml of supernatant was removed from each routine viral culture after 24 h of incubation. A 0.25-ml portion was frozen for HIV antigen detection. The remainder was cocultured for HIV isolation by incubation for 1 h in a 25-cm2 tissue culture flask with 107 fresh, non-phytohemagglutininstimulated HIV antibody-negative donor PBMC; and then 5 x 106 phytohemagglutinin-stimulated donor PBMC and growth medium were added to make a total volume of 10 ml. Cocultures were incubated at 37°C in a 5% C02 atmosphere for up to 28 days. Twice a week, 5 ml of culture medium above the settled PBMC was removed for testing and replaced with an equal volume of fresh medium. An additional 3 x 106 phytohemagglutinin-stimulated donor PBMC were added weekly.
Routine viral culture results. All cultures were negative for the common viruses in all of the cell cultures after 28 days (Table 1) .
HIV culture and antigen detection results. Of the 26 samples, 10 (38%) were positive for HIV antigen when the serum was tested directly ( samples. The data on the positive samples are summarized in Table 2 . In four of these five samples, HIV antigen was detected in cocultured supernatants from all three types of cell cultures. However, HIV antigen was detected only in the cocultured supernatant from the RHMK cell culture tube of patient 21. The routine RHMK cell culture supernatant from this patient was also HIV antigen positive when directly tested 24 h after inoculation.
Our study demonstrated that HIV in concentrations normally found in the blood of patients may survive for at least 24 h in standard clinical virology cell culture systems. These (3, 8) . In contrast to previous studies of survival of HIV in laboratory environments (7) or in certain blood culture systems (4), our study was conducted using a standard clinical virology culture system and specimens from HIVinfected patients rather than laboratory strains of HIV. Although with our HIV blood culture system we recovered HIV from 23 of 24 patients, we were able to demonstrate HIV in cocultures of routine viral culture supernatants from only four subjects, two of whom were asymptomatic. These results were reproduced with a second blood sample from one asymptomatic subject (Tables 1 and 2 ing of blood and body fluids but also during further handling of these specimens in virology laboratories.
